Inspire Medical Systems (INSP) Non Operating Investment Income (2018 - 2025)
Inspire Medical Systems (INSP) reported Non Operating Investment Income of -$47000.0 for Q4 2025, up 95.36% on a YoY basis from -$24058.1 in Q4 2024, and down 115.56% sequentially from $302000.0 in Q3 2025.
Inspire Medical Systems (INSP) Non Operating Investment Income (2018 - 2025) Analysis & Trends
Inspire Medical Systems (INSP) has 8 years of Non Operating Investment Income data on file, last reported at -$47000.0 in Q4 2025.
- For the quarter ending Q4 2025, Non Operating Investment Income rose 95.36% year-over-year to -$47000.0; the trailing twelve-month figure through Dec 2025 stood at $224000.0 (up 212.56% YoY), and the FY2025 full-year result was $224000.0, up 212.56% from the prior year.
- Non Operating Investment Income declined to -$47000.0 in Q4 2025, from $302000.0 in the prior quarter.
- In the past five years, Non Operating Investment Income ranged from a high of $1.6 million in Q3 2024 to a low of -$1.0 million in Q4 2024.
- A 5-year average of $28350.0 and a median of -$17000.0 in 2021 frame the typical range for Non Operating Investment Income.
- Peak annual rise in Non Operating Investment Income reached 1175.41% in 2024, while the deepest fall reached 19900.0% in 2024.
- Tracing INSP's Non Operating Investment Income over 5 years: stood at -$46000.0 in 2021, then jumped by 278.26% to $82000.0 in 2022, then jumped by 646.34% to $612000.0 in 2023, then sank by 265.52% to -$1.0 million in 2024, then surged by 95.36% to -$47000.0 in 2025.
- Business Quant data shows INSP's Non Operating Investment Income at -$47000.0 in Q4 2025, $302000.0 in Q3 2025, and -$22000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Inspire Medical Systems | 1.47 Bn | 1.18 Bn | 176.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -47,000.00 |
| Dec 31, 2025 | -47,000.00 |
| Sep 30, 2025 | 302,000.00 |
| Sep 30, 2025 | 302,000.00 |
| Jun 30, 2025 | -22,000.00 |
| Jun 30, 2025 | -22,000.00 |
| Mar 31, 2025 | -9,000.00 |
| Mar 31, 2025 | -9,000.00 |
| Dec 31, 2024 | -1.01 Mn |
| Dec 31, 2024 | -1.01 Mn |
| Sep 30, 2024 | 1.56 Mn |
| Sep 30, 2024 | 1.56 Mn |
| Jun 30, 2024 | -200,000.00 |
| Jun 30, 2024 | -200,000.00 |
| Mar 31, 2024 | -542,000.00 |
| Mar 31, 2024 | -542,000.00 |
| Dec 31, 2023 | 612,000.00 |
| Dec 31, 2023 | 612,000.00 |
| Sep 30, 2023 | 122,000.00 |
| Sep 30, 2023 | 122,000.00 |